Mkts

Citius Oncology, Inc.

NASDAQ: CTOR
$0.55+0.04 (+7.85%)
As of Nov 9, 4:00 PM ET

Key statistics

Day range
0.520.59
52-week range
0.491.83
Today
Open0.52
Previous close0.55
Volume—
Valuation
Market cap47.37M
P/E ratio—
EPS (TTM)-0.48
Income & risk
Dividend / yield—
Beta3.47
Avg volume110.2K
Discussion

CTOR News

Stories mentioning CTOR from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue1,6673,944
Cost of Goods Sold329.00789.00
Gross Profit1,3383,1550.000.000.000.000.000.00
Operating Expenses
Research & Development1,0791,0181,076938.003,1391,2651,2971,131
Sales General & Admin
Total Operating Expenses29,9528,4074,7124,9457,4716,3956,6694,629
Operating Income (Loss)(28,614)(5,252)(4,712)(4,945)(7,471)(6,395)(4,629)
Interest Income44.0028.00
Interest Expense
Other Expense
Pretax Income(26,841)(5,270)(4,732)(5,106)(7,471)(6,395)(6,669)(4,629)
Tax Provision(231.00)264.00265.00264.00264.00264.00144.00144.00
Net Income (Loss)(26,610)(5,534)(4,996)(5,370)(7,736)(6,659)(6,813)(4,773)
Earnings Per Share (Basic)(0.27)(0.06)(0.07)(0.08)(0.11)(0.09)(0.10)(0.07)
Earnings Per Share (Diluted)(0.27)(0.06)(0.07)(0.08)(0.11)(0.09)(0.10)(0.07)
Weighted Average Shares Outstanding (Basic)100,02787,46273,26871,55271,55271,55268,05467,500
Weighted Average Shares Outstanding (Diluted)100,02787,46273,26871,55271,55271,55268,05467,500

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CTOR

Citius Oncology, Inc. (NASDAQ: CTOR) is a stock listed on the Nasdaq Stock Market under the ticker symbol CTOR. It last traded at $0.5500 (Nov 9, 2026, 4:00 PM ET), up 7.8% on the day. That gives Citius Oncology a market capitalisation of $47.4M.

Over the past 52 weeks CTOR has traded between $0.4900 and $1.83.

Revenue for the quarter ended Mar 31, 2026 was $1.7M; a net loss of $26.6M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$1.7M-$26.6M-1596.3%
Dec 31, 2025$3.9M-$5.5M-140.3%
Sep 30, 2025—-$5.0M—
Jun 30, 2025—-$5.4M—

From Citius Oncology’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…